- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
How a Painkiller Turns Liver-killer
11 October 2002 (All day)
Overdoses of acetaminophen--the widely used painkiller sold under the brand name Tylenol--can cause severe liver damage. Every year in the United States overdoses of the painkiller cause acute liver failure in as many as 800 people, one-third of whom die as a result. New research helps explain just how acetaminophen harms the liver and may provide a target for treating liver failure due to acetaminophen overdoses.
In the 11 October issue of Science, a team led by David Moore of Baylor College of Medicine in Houston, Texas, identifies a key player in acetaminophen toxicity: the so-called constitutive androstane receptor (CAR). Ordinarily, CAR protects the liver by helping it eliminate foreign chemicals, Moore says. But in some cases it has the opposite effect, creating products that are more toxic than the originals.
A clue that CAR might be involved in acetaminophen toxicity came a few years ago. The drug phenobarbital increases susceptibility to acetaminophen damage because it fosters production of two enzymes in the CYP family that convert acetaminophen to a highly toxic compound called NAPQI. The cell normally eliminates NAPQI by tying it up with a detoxifying molecule called glutathione. But if NAPQI production outstrips the glutathione supply, cell damage occurs. CAR comes into the story because Moore and others found that phenobarbital works through that receptor to enhance CYP enzyme production.
Moore and his colleagues now report that CAR is involved even more directly in acetaminophen toxicity. In normal mice, high doses of acetaminophen increased production of the CYP enzymes, as well as an enzyme called GSTPi that attaches glutathione to NAPQI and other molecules. That could be a double whammy for liver cells--increasing NAPQI production at the same time glutathione supplies are depleted. The animals showed signs of severe liver damage. But in animals in which the CAR gene had been inactivated, the same doses of acetaminophen did not increase production of CYP or GSTPi enzymes, and these animals suffered much less liver damage than normal mice. Moore's team also found that androstanol, a compound that inhibits CAR activity, protected mice against acetaminophen-induced liver damage even after exposure to the painkiller. It provided 100% protection 1 hour later and 50% protection 3 hours later.
Moore and his colleagues "have shown clearly that the receptor is important," says Steven Kliewer, a liver toxicity expert at the University of Texas Southwestern Medical Center in Dallas. Although more work will be needed to show whether CAR inhibitors might be useful treatments for human liver toxicities, Kliewer, for one, is hopeful: "The more we understand about the mechanisms [of liver toxicity], the more opportunities we will have for treatment."